Dec 22, 2023 US Food and Drugs Administration (USFDA) has approved TARPEYO (budesonide) delayed release capsules to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. TARPEYO was first approved…


December 14, 2023 The European Commission (EC), the Heads of Medicines Agencies (HMA) and EMA have published the first version of the Union list of critical medicines. It contains more than 200 active substances of medicines for human use considered…

December 13, 2023 WS Global, INC Brooklyn, NY has initiated voluntarily recall of all lots of Himalayan Pain Relief Tea, tea packets to the consumer level. The products have been found to contain undeclared drugs viz. Diclofenac and Dexamethasone.…

18 June, 2022 Central Drugs Standard Control Organization (CDSCO), the central drug regulatory agency of Government of India has published the list of all the vaccines approved in India for the prophylaxis of Covid-19. The data consists of all…

17 June, 2022 Central Drugs Standard Control Organization (CDSCO), the central drug regulatory agency of Government of India has issued a new draft gazette notification to notify Schedule H2 drugs and amendment in Rule 96 of Drugs and Cosmetics…
Recent Post
- CDSCO Introduces Online Process for Additional Variant Applications in Cosmetics
- India Imposes National Ban on Nimesulide for Veterinary Use Due to Toxicity Risks
- Major Relief for MSME Pharma Manufacturers: MoHFW Extends Deadline for Revised GMP Compliance
- Pharmacovigilance system compliance in India
- Simplifying Clinical Trial Amendment Approvals in India